Skip to content
Teneo
Portrait of Robert Mead
Portrait of Paul Haenle
mary-dunphy
Portrait of James Crossland
Portrait of Susanne Deegan
Portrait of Ursula Burns
Diane McIntyre Headshot
Portrait of Megan Shattuck
Radina_Final2
Jacob Lund Nielsen Correct
Tuyen_Do_Bio (002)
jennifer-warmsley_1998-300px
Van Jones
Betsy Cohen_1443
Portrait of Gulum Williams
Rhea Siers
350A1788
Portrait of Sir Craig Oliver
Portrait of Rachel Posner
Juliet Kayyem
Portrait of Kevin Kajiwara
Portrait of Damien Ryan
Portrait of Casey Morgan
Portrait of General Raymond T. Odierno
© 2019 | Kristina Sherk Photography | www.Kristinasherk.com
Pat Russo
Portrait of Emily Blyth
Portrait of Andrea Calise
Portrait of John Judge
Lisa Davis
08_Nick_Claydon_483-300PX
Kathy Deveny
Ginni Rometty
Lauren C Photo Apr2021
Oliver Letwin
Portrait of Michael Madden
Portrait of Kathleen Lacey
Dow_CEO_Andrew_Liveris060917
Sally Osman New
Portrait of Tayo Famakinwa
Portrait of Jimmy Asci
MAW photo_Teneo
Portrait of Rosie Steele
Monika Dricoll
Portrait of William J. Bratton
Portrait of Kristen Lewko Hostetter
Harrison Goldin Image
WilliamEdwardsJacketFinal

People

Menu

Marleen Geerlof

Marleen Geerlof

Managing Director

Marleen Geerlof is a Managing Director with Teneo, based in New York. Marleen counsels clients across a variety of sectors on business-critical issues, with a particular focus on capital markets and shareholder advisory mandates.

She joined Teneo from Brunswick Group where she led a number of complex and cross-border mandates, most notably mergers and acquisitions, shareholder activism defense, and on-going investor engagement mandates. A Dutch national, with experience working across Europe, South Africa and the U.S., Marleen brings a strong international perspective to cross-border mandates and multi-stakeholder campaigns.

Notable transaction experience includes AB InBev’s $106bn acquisition of SABMiller; Barrick’s $6bn merger with Randgold; AkzoNobel’s successful defense against a hostile takeover approach by PPG; Bayer’s $66bn acquisition of Monsanto; and Lafarge’s $50bn merger with Holcim.